Holen Sie sich die Stockscreener-App
2.2808
1.49%
0.0308
Schlusskurs vom Vortag:
$2.25
Offen:
$2.25
24-Stunden-Volumen:
10,433
Relative Volume:
0.03
Marktkapitalisierung:
$6.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.28M
KGV:
-0.7577
EPS:
-3.01
Netto-Cashflow:
$-9.78M
1W Leistung:
-6.02%
1M Leistung:
+8.23%
6M Leistung:
+12.49%
1J Leistung:
-14.38%
1-Tages-Spanne:
$2.25
$2.2867
1-Wochen-Bereich:
$2.24
$2.625
52-Wochen-Spanne:
$1.62
$14.67
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Firmenname
Ensysce Biosciences Inc
Sektor
Branche
Telefon
(858) 263-4196
Adresse
7946 IVANHOE AVENUE, LA JOLLA
Vergleichen Sie ENSC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENSC
Ensysce Biosciences Inc
|
2.2867 | 6.68M | 0 | -11.28M | -9.78M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.28 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.63 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.19 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.57 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.93 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten
Detecting price anomalies in Ensysce Biosciences Inc. with AI2025 Market Outlook & Momentum Based Trading Signals - newser.com
Will Ensysce Biosciences Inc. stock see PE expansionMarket Growth Summary & Risk Managed Trade Strategies - newser.com
Why analysts remain bullish on Ensysce Biosciences Inc. stockJuly 2025 Action & Momentum Based Trading Ideas - newser.com
Will Ensysce Biosciences Inc. bounce back from current supportQuarterly Trade Summary & Community Consensus Trade Signals - newser.com
How sentiment analysis helps forecast Ensysce Biosciences Inc.Earnings Miss & Stock Portfolio Risk Management - newser.com
Building trade automation scripts for Ensysce Biosciences Inc.2025 Trading Volume Trends & Real-Time Volume Spike Alerts - newser.com
Will Ensysce Biosciences Inc. continue its uptrendWeekly Trend Report & Daily Chart Pattern Signals - newser.com
Historical volatility pattern of Ensysce Biosciences Inc. visualizedMarket Risk Summary & Capital Efficient Trading Techniques - newser.com
Will a bounce in Ensysce Biosciences Inc. offer an exitWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
PAINWeek 2025 highlights: Ensysce Biosciences shares symposium video on TAAP™ & MPAR® - Stock Titan
Will Ensysce Biosciences Inc. stock continue upward momentumLayoff News & Verified Short-Term Plans - newser.com
Statistical indicators supporting Ensysce Biosciences Inc.’s strength2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
Weiss Ratings Reaffirms “Sell (E+)” Rating for Ensysce Biosciences (NASDAQ:ENSC) - Defense World
Ensysce Biosciences Inc Stock Analysis and ForecastReal-Time Stock Alerts & Low Cost Trading Plans - earlytimes.in
Applying Elliott Wave Theory to Ensysce Biosciences Inc.Portfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Can trapped investors hope for a rebound in Ensysce Biosciences Inc.Quarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Ranking Ensysce Biosciences Inc. among high performing stocks via tools - newser.com
Full technical analysis of Ensysce Biosciences Inc. stock2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Custom watchlist performance reports with Ensysce Biosciences Inc.Weekly Trade Review & Trade Opportunity Analysis Reports - newser.com
News impact scoring models applied to Ensysce Biosciences Inc.Short Setup & Technical Analysis for Trade Confirmation - newser.com
Evaluating Ensysce Biosciences Inc. with trendline analysisDip Buying & Free Reliable Trade Execution Plans - newser.com
Is Ensysce Biosciences Inc. stock a buy on dips2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
Ensysce Biosciences (NASDAQ:ENSC) Trading Up 1.3% – Should You Buy? - Defense World
Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
2.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):